1Manson, JE, Tosteson, H, Ridker, PM, et al. (1992) The primary prevention of myocardial infarction. N Engl J Med 326, 1406–1416.
2Wilson, MD & Rudel, LL (1994) Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J Lipid Res 35, 943–955.
3Gylling, H & Miettinen, TA (1995) The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis 117, 305–308.
4Altmann, SW, Davis, HR Jr, Zhu, LJ, et al. (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201–1204.
5Miura, S & Saku, K (2008) Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47, 1165–1170.
6Davis, HR Jr, Hoos, LM, Tetzloff, G, et al. (2007) Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in ApoE − / − mice. Arterioscler Thromb Vasc Biol 27, 841–849.
7Davis, HR Jr, Zhu, LJ, Hoos, LM, et al. (2004) Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279, 33586–33592.
8Duval, C, Touche, V, Tailleux, A, et al. (2006) Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 340, 1259–1263.
9Nomiyama, T & Bruemmer, D (2008) Liver X receptors as therapeutic targets in metabolism and atherosclerosis. Curr Atheroscler Rep 10, 88–95.
10Bradley, MN, Hong, C, Chen, M, et al. (2007) Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest 117, 2337–2346.
11Repa, JJ, Turley, SD, Lobaccaro, JA, et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524–1529.
13Rastall, RA, Gibson, GR, Gill, HS, et al. (2005) Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbiol Ecol 52, 145–152.
14Gilliland, SE, Nelson, CR & Maxwell, C (1985) Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 49, 377–381.
15Liong, MT & Shah, NP (2005) Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci 88, 55–66.
16Pereira, DI & Gibson, GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37, 259–281.
17Sanders, ME (2000) Considerations for use of probiotic bacteria to modulate human health. J Nutr 130, 2S Suppl., 384S–390S.
18Ebringer, L, Ferencik, M & Krajcovic, J (2008) Beneficial health effects of milk and fermented dairy products – review. Folia Microbiol (Praha) 53, 378–394.
19Kim, Y, Whang, JY, Whang, KY, et al. (2008) Characterization of the cholesterol-reducing activity in a cell-free supernatant of Lactobacillus acidophilus ATCC 43121. Biosci Biotechnol Biochem 72, 1483–1490.
20Yan, F, Cao, H, Cover, TL, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562–575.
21Liong, MT & Shah, NP (2005) Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J 15, 391–398.